Chemical structure of Morphine

Compound Monograph

Morphine

Alkaloids Isoquinoline Alkaloids Natural (plant-derived)

Morphine is the principal alkaloid of opium and the reference drug for moderate-to-severe pain — a WHO essential medicine with a large randomised record in cancer pain. That record belongs to a standardised, clinician-titrated pharmaceutical; the plant it comes from delivers an unmeasurable dose, and habitual consumption of crude opium is classified as carcinogenic to humans.

Sources · 1

Where Does It Come From?

Morphine is a naturally occurring morphinan alkaloid (benzylisoquinoline-derived opiate), found in Opium poppy. It is flagged as poisonous.

Also found in
Opium poppy Monograph coming soon

Concentration

Content by Source

Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.

Morphine at a Glance

Morphine is the principal alkaloid of opium and the molecule against which every other opioid analgesic is measured. It binds the mu-opioid receptor, and that single action produces both the reason it is on the WHO Model List of Essential Medicines and every one of its hazards: analgesia, sedation, constipation, euphoria, tolerance, dependence and — at enough exposure — the respiratory arrest that kills 7Reference 7Paul AK et al. · 2021ReviewOpioid Analgesia and Opioid-Induced Adverse Effects: A Review — reviewView study →.

Its clinical record is real and specific. A Cochrane review of oral morphine for cancer pain covers 62 studies and 4,241 participants, and the wider Cochrane overview of opioids in cancer pain concludes that roughly 19 people in 20 who can tolerate an opioid have moderate-or-severe pain brought down to mild or none within 14 days 1,2Reference 1Wiffen PJ et al. · 2016Systematic reviewOral morphine for cancer pain — systematic reviewView study →Reference 2Wiffen PJ et al. · 2017Systematic reviewOpioids for cancer pain - an overview of Cochrane reviews — systematic reviewView study →. That is one of the more useful numbers in analgesia — and it is a number about a standardised tablet, prescribed and titrated by a clinician.

The plant is a different subject. Alkaloid content in poppy material varies by orders of magnitude with cultivar, plant part and processing, so a home preparation has no knowable dose 10,13Reference 10Carlin et al. · 2020Opium Alkaloids in Harvested and Thermally Processed Poppy SeedsView study →Reference 13Frick S et al. · 2005Comparative qualitative and quantitative determination of alkaloids in narcotic and condiment Papaver somniferum cultivarsView study →; poppy-seed tea has been shown by mass spectrometry to carry lethal quantities of morphine and has killed people 8,9Reference 8Powers et al. · 2018Quantification of Morphine, Codeine, and Thebaine in Home-Brewed Poppy Seed Tea by LC-MS/MSView study →Reference 9Spyres et al. · 2018Case reportTwo cases of severe opiate toxicity after ingestion of poppy seed tea — case reportView study →; and habitual consumption of crude opium, as distinct from purified morphine, is classified by the International Agency for Research on Cancer as carcinogenic to humans 11,12Reference 11Warnakulasuriya S et al. · 2020ReviewCarcinogenicity of opium consumption — IARC Monographs evaluationView study →Reference 12M Filho A et al. · 2023Meta-analysisThe carcinogenicity of opium consumption: a systematic review and meta-analysis — meta-analysisView study →.

The Drug and the Plant Are Not the Same Thing

Almost everything written about morphine is written about a pharmaceutical: a purified molecule of known mass, in a tablet or ampoule of stated strength, given by someone who can measure the response and reverse an overdose. None of those properties survives the trip back to the plant.

Content is not fixed. In the Tasmanian pharmaceutical cultivar C048-6-14-64, morphine, codeine and thebaine together account for 91.2% of the latex alkaloids. In the condiment cultivar “Marianne”, grown for seed, morphinan alkaloids fall to 18.8% of the total and the latex is dominated instead by narcotoline and noscapine 13Reference 13Frick S et al. · 2005Comparative qualitative and quantitative determination of alkaloids in narcotic and condiment Papaver somniferum cultivarsView study →. Same species, opposite chemistry. Plant part matters too: the alkaloid profile differs between latex, stem, leaf and root, and morphine concentration falls down the stem toward the roots while codeine rises 13Reference 13Frick S et al. · 2005Comparative qualitative and quantitative determination of alkaloids in narcotic and condiment Papaver somniferum cultivarsView study →.

The seed coat is the practical hazard. Culinary poppy seed carries no latex, but seeds are contaminated with alkaloid from the capsule during harvest. When home-brewing recipes taken from user forums were applied to commercially sold seed and the extract quantified by LC-MS/MS, morphine recovery ranged from under 1 to 2,788 mg/kg of seed — and the authors concluded that regardless of extraction conditions, lethal amounts of morphine can be rinsed off poppy seed by these methods 8Reference 8Powers et al. · 2018Quantification of Morphine, Codeine, and Thebaine in Home-Brewed Poppy Seed Tea by LC-MS/MSView study →. Two young men in that study’s originating cases died with high blood morphine at autopsy; a separate report documents two further cases of severe opiate toxicity after poppy-seed tea 8,9Reference 8Powers et al. · 2018Quantification of Morphine, Codeine, and Thebaine in Home-Brewed Poppy Seed Tea by LC-MS/MSView study →Reference 9Spyres et al. · 2018Case reportTwo cases of severe opiate toxicity after ingestion of poppy seed tea — case reportView study →. Thermal processing shifts the load again, so the same seed is not the same exposure before and after cooking 10Reference 10Carlin et al. · 2020Opium Alkaloids in Harvested and Thermally Processed Poppy SeedsView study →.

And the crude material carries a risk the purified drug does not. IARC’s working group classified opium consumption as Group 1, carcinogenic to humans, with the evidence strongest for cancers of the urinary bladder, larynx and lung 11Reference 11Warnakulasuriya S et al. · 2020ReviewCarcinogenicity of opium consumption — IARC Monographs evaluationView study →. An accompanying systematic review and meta-analysis of 2 prospective cohorts and 33 case-control studies put the pooled relative risk for ever-or-regular use at 7.97 (95% CI 4.79–13.3) for laryngeal cancer and 1.50 (1.13–1.99) for oesophageal cancer, with risk rising alongside cumulative exposure 12Reference 12M Filho A et al. · 2023Meta-analysisThe carcinogenicity of opium consumption: a systematic review and meta-analysis — meta-analysisView study →. This is a finding about smoked and eaten opium — a complex, pyrolysed mixture — not about morphine as a molecule, and it is one of the clearest cases anywhere of a plant preparation and its purified constituent pointing in opposite directions.

Established Medical Use

Oral morphine remains the reference analgesic for moderate-to-severe cancer pain, in immediate-release and modified-release forms, and modified-release products hold for 12 or 24 hours depending on formulation 1Reference 1Wiffen PJ et al. · 2016Systematic reviewOral morphine for cancer pain — systematic reviewView study →. It is used across acute severe pain, post-operative pain and palliative care, and it is one of the few drugs on the WHO essential-medicines list with no adequate substitute for its indication.

The access story is the counterweight to the overdose story. The Lancet Commission on Palliative Care and Pain Relief documented an enormous global imbalance in the distribution of morphine-equivalent opioids, in which the countries with the greatest burden of untreated terminal pain receive a small fraction of the supply — a shortage of a cheap, off-patent, plant-derived medicine, sustained largely by regulation and procurement rather than by cost 19Reference 19Knaul FM et al. · 2018ReviewAlleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report — reviewView study →. Morphine is simultaneously one of the most over-prescribed and one of the most under-supplied medicines in the world, depending on where the question is asked.

Morphine Is Partly Its Own Prodrug

The most counter-intuitive fact about morphine is that much of its analgesia is not performed by morphine.

Morphine is heavily glucuronidated in the liver, chiefly by UGT2B7, into two metabolites with completely different behaviour. Morphine-3-glucuronide (M3G) is the larger fraction and is not an analgesic at all — it does not activate the mu receptor and is implicated instead in the neuroexcitatory effects (myoclonus, hyperalgesia, agitation) seen at high exposure. Morphine-6-glucuronide (M6G) is a mu agonist of higher affinity than the parent. Both are highly water-soluble, but only M6G crosses the blood-brain barrier in meaningful quantity 6Reference 6De Gregori S et al. · 2012ReviewMorphine metabolism, transport and brain disposition — reviewView study →.

Working from published receptor-binding, protein-binding and concentration data, a quantitative review estimated M6G’s share of the total mu-receptor-mediated analgesic effect at 96.6% after oral morphine, and 85–91% after subcutaneous, intravenous and rectal dosing 5Reference 5Klimas R · 2014ReviewMorphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide — reviewView study →. Because M6G is cleared renally and accumulates when the kidneys do not clear it, that share rises to an estimated 97.6% in renal insufficiency — which is why the authors argue morphine may be regarded as a prodrug, and why kidney function, not liver function, is the variable that most often forces a dose change 5,6Reference 5Klimas R · 2014ReviewMorphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide — reviewView study →Reference 6De Gregori S et al. · 2012ReviewMorphine metabolism, transport and brain disposition — reviewView study →.

Two practical consequences follow. Oral morphine and injected morphine are not simply the same drug at different bioavailabilities — the oral route, with its heavier first-pass glucuronidation, delivers proportionally more of the active metabolite. And renal impairment is a genuine accumulation hazard rather than a theoretical one, because the compound that does the work is the one the kidney is failing to remove 5,6Reference 5Klimas R · 2014ReviewMorphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide — reviewView study →Reference 6De Gregori S et al. · 2012ReviewMorphine metabolism, transport and brain disposition — reviewView study →.

What It's Used For

Morphine’s evidence base is unusually lopsided: enormous in cancer pain, thin and equivocal everywhere else, and absent for anything the plant can deliver.

Cancer pain is the anchor.62 randomised studies and 4,241 participants for oral morphine; across the wider opioid overview, about 19 in 20 tolerant patients reach mild-or-no pain within 14 days. Cochrane rates the quality of that evidence as very low — the trials are old, small, and were designed to compare formulations rather than to beat placebo 1,2Reference 1Wiffen PJ et al. · 2016Systematic reviewOral morphine for cancer pain — systematic reviewView study →Reference 2Wiffen PJ et al. · 2017Systematic reviewOpioids for cancer pain - an overview of Cochrane reviews — systematic reviewView study →.
The same molecule does not transfer to neuropathic pain.A dedicated Cochrane review of five cross-over trials in 236 participants found insufficient evidence to support or refute any efficacy of morphine in neuropathic pain 3Reference 3Cooper TE et al. · 2017Systematic reviewMorphine for chronic neuropathic pain in adults — systematic reviewView study →.
The mechanism is the risk.Analgesia, euphoria, constipation, sedation, tolerance and fatal respiratory depression are all mu-opioid receptor effects; they are not separable side effects of a separable action 7Reference 7Paul AK et al. · 2021ReviewOpioid Analgesia and Opioid-Induced Adverse Effects: A Review — reviewView study →.
Nothing in this record belongs to the plant.Every trial used a standardised pharmaceutical at a measured dose. Poppy preparations have no efficacy literature and a documented fatality literature 8,9Reference 8Powers et al. · 2018Quantification of Morphine, Codeine, and Thebaine in Home-Brewed Poppy Seed Tea by LC-MS/MSView study →Reference 9Spyres et al. · 2018Case reportTwo cases of severe opiate toxicity after ingestion of poppy seed tea — case reportView study →.
Evidence by IndicationStrength of support · Beta

Mechanisms

Target / pathwayEffectRelevant to
Mu-opioid receptor (MOR)agonist — inhibits ascending nociceptive transmission and activates descending inhibition
analgesiaand every adverse effect below
Mu receptors in the brainstem respiratory centresreduced sensitivity to rising CO₂ → hypoventilation, then apnoea
fatal overdose
Mu receptors in the enteric nervous systemslowed propulsive motility, increased fluid absorption
constipation; the antidiarrhoeal action
Mesolimbic dopamine signalling (disinhibition of VTA neurons)reward, euphoria, reinforcement
dependence and addiction
Receptor desensitisation, internalisation and adaptive signallingtolerance with repeated exposure; withdrawal on cessation
dose escalationphysical dependence
UGT2B7 glucuronidation → M6Ghigher-affinity mu agonist that crosses the blood-brain barrier
most of the analgesic effect after any route
UGT2B7 glucuronidation → M3Gnon-analgesic; associated with neuroexcitation at high exposure
myoclonusagitationhyperalgesia

The row that matters is the first one. Morphine has no separate “good” receptor — the analgesia and the respiratory depression come from the same target, which is why titration and monitoring, rather than a safer dose, are the whole of clinical practice 7Reference 7Paul AK et al. · 2021ReviewOpioid Analgesia and Opioid-Induced Adverse Effects: A Review — reviewView study →.

Pharmacokinetics

Oral morphine is absorbed well but subjected to heavy first-pass metabolism, so oral bioavailability is a fraction of the injected equivalent and oral doses run considerably higher than parenteral ones for the same effect 6Reference 6De Gregori S et al. · 2012ReviewMorphine metabolism, transport and brain disposition — reviewView study →. Metabolism is glucuronidation rather than oxidation — chiefly by UGT2B7, with interindividual variation in that enzyme and in the transport proteins moving the metabolites across the blood-brain barrier 6Reference 6De Gregori S et al. · 2012ReviewMorphine metabolism, transport and brain disposition — reviewView study →. The products are M3G in larger quantity and M6G in smaller, and it is M6G that supplies most of the analgesia, at an estimated 96.6% of the effect after oral dosing 5Reference 5Klimas R · 2014ReviewMorphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide — reviewView study →. Both glucuronides are cleared by the kidney, so renal impairment causes accumulation of the active metabolite and prolongs both analgesia and risk — the practical reason morphine is dose-reduced or avoided in renal failure 5,6Reference 5Klimas R · 2014ReviewMorphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide — reviewView study →Reference 6De Gregori S et al. · 2012ReviewMorphine metabolism, transport and brain disposition — reviewView study →. Because the pathway is glucuronidation, morphine sits outside most of the CYP-mediated interaction burden that complicates codeine, tramadol and oxycodone; its dangerous interactions are pharmacodynamic, with other CNS depressants 7Reference 7Paul AK et al. · 2021ReviewOpioid Analgesia and Opioid-Induced Adverse Effects: A Review — reviewView study →.

Clinical Trials

Morphine is not an experimental agent; the relevant record is a completed one. Cochrane has synthesised the randomised literature across cancer pain (62 studies), neuropathic pain (5 studies) and breathlessness in advanced disease (26 studies), and the recurring theme is that a drug in universal use has been tested less rigorously than its status implies 1,3,4Reference 1Wiffen PJ et al. · 2016Systematic reviewOral morphine for cancer pain — systematic reviewView study →Reference 3Cooper TE et al. · 2017Systematic reviewMorphine for chronic neuropathic pain in adults — systematic reviewView study →Reference 4Barnes H et al. · 2016Meta-analysisOpioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness — meta-analysisView study →.

CompletedPlannedTerminatedPreclinical
Extensive — cancer pain, neuropathic pain, palliative breathlessness (all Cochrane-synthesised)——Mechanistic work on tolerance, hyperalgesia and metabolite pharmacology

Last checked: September 2026.

Isolate vs. Plant Studies

This molecule is a clean case: the entire human evidence base is isolate evidence, and that is a strength rather than a caveat. Every trial in the Cochrane reviews used pharmaceutical morphine sulfate or hydrochloride at a stated dose, in a stated formulation, titrated against a measured response 1,2,3,4Reference 1Wiffen PJ et al. · 2016Systematic reviewOral morphine for cancer pain — systematic reviewView study →Reference 2Wiffen PJ et al. · 2017Systematic reviewOpioids for cancer pain - an overview of Cochrane reviews — systematic reviewView study →Reference 3Cooper TE et al. · 2017Systematic reviewMorphine for chronic neuropathic pain in adults — systematic reviewView study →Reference 4Barnes H et al. · 2016Meta-analysisOpioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness — meta-analysisView study →.

There is no corresponding literature for whole opium or any poppy preparation as a therapy, and the reason is structural rather than accidental: the raw material cannot be dosed. Alkaloid content varies severalfold between cultivars, plant parts and processing methods 13Reference 13Frick S et al. · 2005Comparative qualitative and quantitative determination of alkaloids in narcotic and condiment Papaver somniferum cultivarsView study →, and the one place where a home preparation has been quantified — poppy-seed tea — the measured range spanned more than three orders of magnitude in the same study 8Reference 8Powers et al. · 2018Quantification of Morphine, Codeine, and Thebaine in Home-Brewed Poppy Seed Tea by LC-MS/MSView study →. The evidence that does exist for habitual crude-opium use is epidemiological and negative: Group 1 carcinogenicity for bladder, larynx and lung 11,12Reference 11Warnakulasuriya S et al. · 2020ReviewCarcinogenicity of opium consumption — IARC Monographs evaluationView study →Reference 12M Filho A et al. · 2023Meta-analysisThe carcinogenicity of opium consumption: a systematic review and meta-analysis — meta-analysisView study →.

So the usual isolate-versus-plant caution runs backwards here. The concern with most plant constituents is that isolate data are being used to sell a herb; the concern with morphine is that a plant is being used to approximate a drug whose entire value rests on knowing the dose.

Prevalence in Nature

Morphine is essentially a single-species molecule. It occurs in the latex of the opium poppy (Papaver somniferum), which produces around a hundred different benzylisoquinoline alkaloids, and it is absent or trace-level in the other Papaver species that have been examined for morphinan production 14,15Reference 14Vadhel A et al. · 2023ReviewOpium alkaloids, biosynthesis, pharmacology and association with cancer occurrence — reviewView study →Reference 15Beaudoin GA · 2014ReviewBenzylisoquinoline alkaloid biosynthesis in opium poppy — reviewView study →.

Within the plant it is not evenly spread. The dried latex of a pharmaceutical cultivar is dominated by the morphinans — 91.2% of latex alkaloids as morphine, codeine and thebaine in the Tasmanian elite line C048-6-14-64 — while roots accumulate a different class entirely, chiefly sanguinarine and its relatives. Stems show a gradient, with morphine decreasing and codeine increasing toward the base of the plant 13Reference 13Frick S et al. · 2005Comparative qualitative and quantitative determination of alkaloids in narcotic and condiment Papaver somniferum cultivarsView study →. A condiment cultivar grown for seed inverts the picture: 18.8% morphinans, with narcotoline and noscapine making up 80.5% of latex alkaloids 13Reference 13Frick S et al. · 2005Comparative qualitative and quantitative determination of alkaloids in narcotic and condiment Papaver somniferum cultivarsView study →. Culinary seed itself carries no latex, but is contaminated with alkaloid from the capsule at harvest — which is the whole basis of the poppy-seed exposure literature 8,10Reference 8Powers et al. · 2018Quantification of Morphine, Codeine, and Thebaine in Home-Brewed Poppy Seed Tea by LC-MS/MSView study →Reference 10Carlin et al. · 2020Opium Alkaloids in Harvested and Thermally Processed Poppy SeedsView study →.

Its Role in Plants

Morphine sits at the end of a long biosynthetic branch. All of the poppy’s benzylisoquinoline alkaloids descend from L-tyrosine by way of (S)-reticuline, the branch-point intermediate from which the pathway divides toward the morphinans, the phthalideisoquinolines such as noscapine, and the 1-benzylisoquinolines such as papaverine 14,15Reference 14Vadhel A et al. · 2023ReviewOpium alkaloids, biosynthesis, pharmacology and association with cancer occurrence — reviewView study →Reference 15Beaudoin GA · 2014ReviewBenzylisoquinoline alkaloid biosynthesis in opium poppy — reviewView study →. The morphinan branch runs through salutaridine and thebaine and then to codeine and morphine, and the enzymes committing carbon to it — including salutaridine reductase — are expressed at higher levels in P. somniferum than in Papaver species that make no morphinans, which appears to be what confines the molecule to this one plant 15Reference 15Beaudoin GA · 2014ReviewBenzylisoquinoline alkaloid biosynthesis in opium poppy — reviewView study →.

The alkaloids are made and stored in the laticifers, the specialised cells that produce the latex, which is consistent with a defensive role: a bitter, neuroactive exudate released at the site of damage. That is plant biology, not pharmacology — the poppy is not making an analgesic.

Discovery & Synthesis

Morphine’s isolation is a founding event in pharmacology. Working in Paderborn in the first years of the nineteenth century, the apothecary’s assistant Friedrich Sertürner separated a crystalline base from opium and set out the work in full in his 1817 paper in Annalen der Physik, alongside meconic acid 17Reference 17Sertuerner · 1817Ueber das Morphium, eine neue salzfähige Grundlage, und die Mekonsäure, als Hauptbestandtheile des OpiumsView study →. He named it after Morpheus for its soporific effect. It was the first alkaloid ever isolated from a plant, and it established the idea that a plant drug’s activity could be traced to a single definable compound — the principle the rest of the discipline is built on 16,17Reference 16Brook K et al. · 2017The Chemical History of Morphine: An 8000-year Journey, from Resin to de-novo SynthesisView study →Reference 17Sertuerner · 1817Ueber das Morphium, eine neue salzfähige Grundlage, und die Mekonsäure, als Hauptbestandtheile des OpiumsView study →.

Structural elucidation took another 130 years; Robert Robinson’s derivation of the structural formula was recognised with the 1947 Nobel Prize in Chemistry 16Reference 16Brook K et al. · 2017The Chemical History of Morphine: An 8000-year Journey, from Resin to de-novo SynthesisView study →. The first total synthesis was achieved by Marshall Gates and Gilg Tschudi at the University of Rochester in 1952 18Reference 18Gates M · 1952The Synthesis of MorphineView study →, later published in full detail — a landmark of synthetic organic chemistry that solved the molecule’s five contiguous stereocentres and its bridged pentacyclic skeleton.

Manufacture today is still agricultural. No total synthesis has ever come close to competing on cost with extraction from licensed poppy crops, so the world’s morphine, and the thebaine that feeds most semi-synthetic opioids, is still farmed 16Reference 16Brook K et al. · 2017The Chemical History of Morphine: An 8000-year Journey, from Resin to de-novo SynthesisView study →. That leaves the supply of an essential medicine dependent on a small number of licensed growing countries — the economic and political fact behind both the access shortfall and the diversion problem 16,19Reference 16Brook K et al. · 2017The Chemical History of Morphine: An 8000-year Journey, from Resin to de-novo SynthesisView study →Reference 19Knaul FM et al. · 2018ReviewAlleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report — reviewView study →.

Patents: not yet researched.

Toxicity & Safety

Morphine is flagged poisonous on the strength of a single mechanism: enough of it stops breathing. This is not a rare idiosyncratic reaction but the predictable high end of the same dose-response curve that produces the analgesia.

Safety at a Glance
PoisonousOverdose riskDependence riskControlled substanceSedative interactions
  • A clinician-titrated pharmaceutical has a well-characterised safety profile. Adverse effects are common but predictable, and overdose is reversible with naloxone if it is recognised in time.
  • Respiratory depression is the killing mechanism. Mu agonism blunts the brainstem response to carbon dioxide; the risk multiplies with alcohol, benzodiazepines, gabapentinoids and any other CNS depressant.
  • Tolerance and physical dependence develop with repeated use, and withdrawal on stopping is a physiological event, not a failure of will.
  • Renal impairment causes the active metabolite to accumulate. M6G is cleared by the kidney and does most of the analgesic work, so failing kidneys turn a stable dose into a rising one.
  • No poppy preparation has a knowable dose, and habitual crude-opium consumption is classified as carcinogenic to humans.
Full Safety & Interactions Detail

Respiratory depression and overdose. All clinically used opioids are mu-opioid receptor agonists, and the major adverse effects are direct consequences of that receptor action 7Reference 7Paul AK et al. · 2021ReviewOpioid Analgesia and Opioid-Induced Adverse Effects: A Review — reviewView study →. Mu agonism in the brainstem reduces the ventilatory response to rising carbon dioxide; as dose rises past the analgesic range, breathing slows and then stops. Risk is highest in the opioid-naive, in sleep-disordered breathing, and — above all — in combination with other central nervous system depressants, which is a pharmacodynamic interaction and does not require any metabolic pathway to be shared.

Tolerance, dependence and hyperalgesia. Repeated exposure produces analgesic tolerance and physical dependence through receptor desensitisation and downstream adaptive signalling, and these are among the reasons for dose escalation and patient non-compliance in long-term use 7Reference 7Paul AK et al. · 2021ReviewOpioid Analgesia and Opioid-Induced Adverse Effects: A Review — reviewView study →. A related and less intuitive phenomenon is opioid-induced hyperalgesia — increased pain sensitivity caused by the opioid itself. A meta-analysis of post-surgical patients found that higher intra-operative opioid doses were associated with greater pain and greater morphine consumption in the first 24 hours after surgery, the opposite of the intended effect 20Reference 20Fletcher D · 2014Meta-analysisOpioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis — meta-analysisView study →.

Renal impairment. Because M6G supplies the large majority of the analgesic effect and is renally cleared, kidney function is the dominant determinant of how much drug a given dose actually delivers; in renal insufficiency an estimated 97.6% of the effect after oral dosing is metabolite-driven, and accumulation over successive doses is the expected behaviour rather than the exception 5Reference 5Klimas R · 2014ReviewMorphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide — reviewView study →. M3G, the non-analgesic metabolite, accumulates too and is associated with neuroexcitatory phenomena such as myoclonus and agitation 6Reference 6De Gregori S et al. · 2012ReviewMorphine metabolism, transport and brain disposition — reviewView study →.

Common effects. Constipation, nausea and vomiting, sedation, pruritus, urinary retention and dizziness are frequent; in the cancer-pain trials adverse events were common and predictable, and around 6% of participants discontinued because of them 1Reference 1Wiffen PJ et al. · 2016Systematic reviewOral morphine for cancer pain — systematic reviewView study →. Constipation in particular does not attenuate with time the way sedation does.

Interactions. Morphine is glucuronidated rather than oxidised, so it largely avoids the CYP-mediated interactions that dominate the opioid class. The interactions that matter are additive CNS depression — alcohol, benzodiazepines, gabapentinoids, sedating antihistamines, other opioids — and anything that impairs renal clearance of the glucuronide metabolites 5,6,7Reference 5Klimas R · 2014ReviewMorphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide — reviewView study →Reference 6De Gregori S et al. · 2012ReviewMorphine metabolism, transport and brain disposition — reviewView study →Reference 7Paul AK et al. · 2021ReviewOpioid Analgesia and Opioid-Induced Adverse Effects: A Review — reviewView study →.

Crude opium and carcinogenicity. This is a hazard of the raw plant material, not of the purified molecule. IARC classifies opium consumption as Group 1, carcinogenic to humans, with sufficient evidence for bladder, larynx and lung cancer 11Reference 11Warnakulasuriya S et al. · 2020ReviewCarcinogenicity of opium consumption — IARC Monographs evaluationView study →; the supporting meta-analysis reports pooled relative risks up to 7.97 for laryngeal cancer among ever-or-regular users, with a dose-response relationship across cumulative exposure 12Reference 12M Filho A et al. · 2023Meta-analysisThe carcinogenicity of opium consumption: a systematic review and meta-analysis — meta-analysisView study →. Morphine as an isolated drug carries no such classification.

Reproductive note. Opioid alkaloids cross the placenta and pass into breast milk, and neonatal opioid withdrawal following maternal use is a recognised outcome; poppy-seed tea has been a documented exposure route. Pregnancy and lactation decisions belong to the prescribing context, where the preparation and dose are known.

Morphine is a controlled substance in essentially every jurisdiction and is not available for self-directed use. Nothing here is a protocol; overdose reversal, dose selection and tapering are clinical procedures.

Dosage

Morphine has no self-administered dose, and none can be derived from a plant. What follows is what was used in the trials.

SettingFormDose used in research
Cancer pain (Cochrane, 62 studies)Oral, immediate- or modified-release25–2,000 mg/day, most study averages 100–250 mg/day, reached by titration 1Reference 1Wiffen PJ et al. · 2016Systematic reviewOral morphine for cancer pain — systematic reviewView study →
Chronic neuropathic pain (Cochrane, 5 studies)OralTitrated to 90–180 mg/day or the maximum tolerated dose 3Reference 3Cooper TE et al. · 2017Systematic reviewMorphine for chronic neuropathic pain in adults — systematic reviewView study →
Refractory breathlessness (Cochrane, 26 studies)Oral or parenteralLow doses relative to analgesic use; nebulised route not supported 4Reference 4Barnes H et al. · 2016Meta-analysisOpioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness — meta-analysisView study →

The spread in that first row is the point: an eighty-fold range of daily doses, all of them correct for the patient they were titrated in. Morphine has no standard dose, only a starting dose and a method. Oral and parenteral doses are not interchangeable, since first-pass glucuronidation changes both the quantity and the metabolite mix that reaches the receptor 5,6Reference 5Klimas R · 2014ReviewMorphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide — reviewView study →Reference 6De Gregori S et al. · 2012ReviewMorphine metabolism, transport and brain disposition — reviewView study →.

Poppy preparations have no dose at all. In the one study to quantify a home method, morphine yield from commercial poppy seed spanned under 1 to 2,788 mg/kg, varied between extractions of the same material, and reached lethal quantities by every recipe tested 8Reference 8Powers et al. · 2018Quantification of Morphine, Codeine, and Thebaine in Home-Brewed Poppy Seed Tea by LC-MS/MSView study →.

These are doses recorded in research and clinical practice, not a personal recommendation.

References

  1. Wiffen PJ, Wee B, Moore RA (2016). Oral morphine for cancer pain — systematic review. Cochrane Database Syst Rev. https://pubmed.ncbi.nlm.nih.gov/27105021/
  2. Wiffen PJ, Wee B, Derry S, et al. (2017). Opioids for cancer pain - an overview of Cochrane reviews — systematic review. Cochrane Database Syst Rev. https://pubmed.ncbi.nlm.nih.gov/28683172/
  3. Cooper TE, Chen J, Wiffen PJ, et al. (2017). Morphine for chronic neuropathic pain in adults — systematic review. Cochrane Database Syst Rev. https://pubmed.ncbi.nlm.nih.gov/28530786/
  4. Barnes H, McDonald J, Smallwood N, et al. (2016). Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness — meta-analysis. Cochrane Database Syst Rev. https://pubmed.ncbi.nlm.nih.gov/27030166/
  5. Klimas R, Mikus G (2014). Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide — review. Br J Anaesth. https://pubmed.ncbi.nlm.nih.gov/24985077/
  6. De Gregori S, De Gregori M, Ranzani GN, et al. (2012). Morphine metabolism, transport and brain disposition — review. Metab Brain Dis. https://pubmed.ncbi.nlm.nih.gov/22193538/
  7. Paul AK, Smith CM, Rahmatullah M, et al. (2021). Opioid Analgesia and Opioid-Induced Adverse Effects: A Review — review. Pharmaceuticals (Basel). https://pubmed.ncbi.nlm.nih.gov/34832873/
  8. Powers, Erickson, Swortwood (2018). Quantification of Morphine, Codeine, and Thebaine in Home-Brewed Poppy Seed Tea by LC-MS/MS. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.13664
  9. Spyres, van Wijk, Lapoint, et al. (2018). Two cases of severe opiate toxicity after ingestion of poppy seed tea — case report. Toxicology Communications. https://doi.org/10.1080/24734306.2018.1540178
  10. Carlin, Dean, Ames (2020). Opium Alkaloids in Harvested and Thermally Processed Poppy Seeds. Frontiers in Chemistry. https://doi.org/10.3389/fchem.2020.00737
  11. Warnakulasuriya S, Cronin-Fenton D, Jinot J, et al. (2020). Carcinogenicity of opium consumption — IARC Monographs evaluation. The Lancet Oncology. https://doi.org/10.1016/S1470-2045(20)30611-2
  12. M Filho A, Turner MC, Warnakulasuriya S, et al. (2023). The carcinogenicity of opium consumption: a systematic review and meta-analysis — meta-analysis. Eur J Epidemiol. https://pubmed.ncbi.nlm.nih.gov/36773182/
  13. Frick S, Kramell R, Schmidt J, et al. (2005). Comparative qualitative and quantitative determination of alkaloids in narcotic and condiment Papaver somniferum cultivars. J Nat Prod. https://pubmed.ncbi.nlm.nih.gov/15921406/
  14. Vadhel A, Bashir S, Mir AH, et al. (2023). Opium alkaloids, biosynthesis, pharmacology and association with cancer occurrence — review. Open Biol. https://pubmed.ncbi.nlm.nih.gov/37132222/
  15. Beaudoin GA, Facchini PJ (2014). Benzylisoquinoline alkaloid biosynthesis in opium poppy — review. Planta. https://pubmed.ncbi.nlm.nih.gov/24671624/
  16. Brook K, Bennett J, Desai SP (2017). The Chemical History of Morphine: An 8000-year Journey, from Resin to de-novo Synthesis. J Anesth Hist. https://pubmed.ncbi.nlm.nih.gov/28641826/
  17. Sertuerner (1817). Ueber das Morphium, eine neue salzfähige Grundlage, und die Mekonsäure, als Hauptbestandtheile des Opiums. Annalen der Physik. https://doi.org/10.1002/andp.18170550104
  18. Gates M, Tschudi G (1952). The Synthesis of Morphine. Journal of the American Chemical Society. https://doi.org/10.1021/ja01124a538
  19. Knaul FM, Farmer PE, Krakauer EL, et al. (2018). Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report — review. Lancet. https://pubmed.ncbi.nlm.nih.gov/29032993/
  20. Fletcher D, Martinez V (2014). Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis — meta-analysis. Br J Anaesth. https://pubmed.ncbi.nlm.nih.gov/24829420/